Patents Assigned to Aptinyx Incorporated
  • SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
    Publication number: 20160368926
    Abstract: Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
    Type: Application
    Filed: February 22, 2016
    Publication date: December 22, 2016
    Applicant: Aptinyx Incorporated
    Inventors: John A. Lowe, III, M. Amin Khan